Research study Program year 2020 Source: CMS Open Payments

A Long Term, Randomised, Double Blind, Placebo-Controlled Study to Det

Research payments

$391,807

102 payments

Through program year 2020, $391,807 in research payments was reported against A Long Term, Randomised, Double Blind, Placebo-Controlled Study to Det, across 102 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$73,959	14
2019	Research	$317,848	88

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $391,807 102 payments

Who received the money Research payments · program years 2019–2020

Duke University Organisation paid for research $53,126 7 payments
Iowa Diabetes & Endocrinology Organisation paid for research $25,771 1 payment
Healtheast Medical Res Institute Organisation paid for research $18,859 3 payments
Searcy Medical Center Organisation paid for research $17,348 4 payments
Diabetes And Thyroid Center Of Fort Worth PLLC Organisation paid for research $15,921 1 payment
Academy Of Diabetes Organisation paid for research $15,406 1 payment
Lycoming Internal Medicine Organisation paid for research $12,974 2 payments
Linfritz Research Institute Organisation paid for research $12,597 1 payment
Clear Clinical Research LLC Organisation paid for research $12,489 2 payments
Consano Clinical Research LLC Organisation paid for research $10,058 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.